Biophilia Tracker Bioresonance Therapy

The German doctor Franz Morell is considered the “father” of bioresonance treatment. In 1977, having long-term experience in electro-acupuncture, he thought that his treatments could be more precise if he could use the electromagnetic vibrations of the patient’s own body. Thus, the first electronic device that could receive and return electromagnetic frequencies from/to the body using electrodes was constructed. Morell introduced the treatment model using the signals of the patient’s own body, which was initially called the MORA treatment. Its name was given by the initials of its inventors MOrell and RAsche, who was an electronic engineer and designed the first treatment device. The use of the BIOPHILIA TACKER device started in 1987, offering many advantages as compared to the initial device. The body receives the disturbed signal from the patient through the input of the information from the abdominal area (as well as any part of the body). This signal is being processed by the BIOPHILIA TACKER device and amplified. Following this, the inverted therapeutic signal returns to the patient amplified through the modulation mat located along the spinal cord. BIOPHILIA TACKER bioresonance device allows the selection of specific parts of the total frequency spectrum for the treatment. The device’s scanning frequency range from 1Hz to 800kHz and it is CE certified. To treat allergies, the modified (inverted) electromagnetic vibrations of allergens are sent to the body, which are placed in a container attached to the bio resonance device.

In the endogenous form of bioresonance, the oscillations are picked up using electrodes at various parts of the body and following an electronic inversion they are transmitted back to the body for therapeutic purposes. In the exogenous form, the oscillations of bio-active substances are transmitted following the electronic inversion (e.g. an allergen) or amplification (e.g. nosodes) for therapeutic purposes to the human body. In 1990, the pediatrician Dr. Schumacher conducted a research study in his medical practice, including 204 children with various allergies. The patients completed a questionnaire at baseline, and then five to nine months after the BIOPHILIA TACKER bioresonance treatment, the majority (83%) reported that they did not have any allergic symptoms anymore. The symptoms improved in 11% of the respondents, no difference was reported by 4.5% of them, and 1.5% could not specify. At that time, this was a revolutionary finding. The level of evidence for the study was 4-5. During the same period Dr. Schumacher published another study with patients with high fever (spring allergic rhinitis). In the following spring after the treatment, 43.4% of the patients did not have symptoms anymore, while improvement was evident in 50.4% of the patients, indicating that effectiveness exceeded 90%.